Connect Biopharma Holdings Limited (CNTB) Social Stream
Connect Biopharma Holdings Ltd (CNTB) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Connect Biopharma Holdings Ltd.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
CNTB Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for CNTB as an investment opportunity.
- Connect Biopharma Holdings Ltd's upside potential (average analyst target price relative to current price) is greater than 195.64% of all US stocks.
- In the context of all US stocks, Connect Biopharma Holdings Ltd's number of analysts covering the stock is higher than 22.28% of them.
- Connect Biopharma Holdings Ltd's variance in analysts' estimates is lower than 66.62% of Pharmaceutical Products stocks.
- Connect Biopharma Holdings Ltd's average analyst price target is higher than 119.55% of stocks in the small market cap category.
In the Pharmaceutical Products industry, CNTA, CNCE, and CMPS are the three stocks most similar to Connect Biopharma Holdings Ltd regarding the price target and analyst recommendation information presented here.
Is CNTB a Buy, Hold or Sell? See the POWR Ratings now!